CHRISTUS adds tech for early lung cancer detection

CHRISTUS Santa Rosa Hospital - New Braunfels announced today it is now offering a new minimally invasive procedure that will help experts find and diagnose lung cancer earlier.

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women in the U.S. Lung cancer is also the leading cause of death in the U.S, accounting for about one in five of all cancer deaths.

This breakthrough technology is the first of its kind for the community. The Ion Robotic Navigational Bronchoscopy is a tool that allows physicians to get more precise biopsies of masses that were previously not accessible by traditional procedures, while also minimizing the risks.

“This new technology allows us to detect lung cancer early so intervention can start now,” said Dr. Rajesh Shetty, pulmonologist for CHRISTUS Santa Rosa Hospital – New Braunfels. “Often times people learn of their lung cancer after it has already spread. This changes that. Most importantly, our patients have a safer alternative with this minimally invasive approach.”

During the procedure, the catheter is inserted through the patient’s mouth and throat, entering their lungs. This reduces the chance of complications.

“We are committed to providing our patients with the most innovative and technologically advanced health care,” said Genifer Rucker, president of CHRISTUS Santa Rosa Hospital – New Braunfels. “I am so proud that we can offer this type of service to our community. They can receive this type of care, here at home, without having to travel.”

CHRISTUS Santa Rosa Hospital – New Braunfels utilized the technology for the first time today. Shetty and his team extracted a biopsy from a patient and will work with them on their next steps.